BNF:

7.3.1

Status:

Grey

Decision Date:

None

Comments

GREY second line to formulary options for combined oral contraception. For women who have demonstrated or are deemed to be at substantial risk of poor compliance with combined oral contraception. Evra patches are significantly more expensive than the combined oral contraception.

search again